Halozyme Therapeutics financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$0.00M | $0.13M | $0.98M | $3.80M | $8.76M | $13.67M | $13.62M | $56.09M | $42.33M | $54.80M | $75.33M | $135.06M | $146.69M | $316.61M | $151.86M | $195.99M | $267.59M | $443.31M | $660.12M | $829.25M | $0.00M |
| GM % | Gross Margin % |
|
0.00% | 59.15% | 0.00% | 0.00% | 0.00% | -298.53% | -278.44% | -3.09% | -68.08% | -87.75% | -34.51% | 9.31% | -25.47% | 42.58% | -5.61% | 13.70% | 71.00% | 73.59% | 68.81% | 67.59% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -35.37% | -126.70% | -146.78% | -82.08% | -20.33% | -56.72% | 25.58% | -45.65% | -20.01% | 53.91% | 62.24% | 43.85% | 41.01% | 0.00% |
| EPS | Earnings Per Share |
|
$-0.26 | $-0.24 | $-0.32 | $-0.61 | $-0.67 | $-0.56 | $-0.19 | $-0.48 | $-0.74 | $-0.56 | $-0.25 | $-0.81 | $0.45 | $-0.56 | $-0.50 | $0.91 | $2.00 | $2.21 | $2.74 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 0.00% | -0.00% | -0.00% | 0.00% | 0 | 0 | 0 | 0 |
| Sha. | Shares |
|
47.63m | 50.05m | 64.36m | 68.65m | 77.8m | 91.45m | 100.2m | 101.29m | 111.99m | 112.74m | 123.85m | 126.86m | 128.68m | 141.06m | 143.78m | 146.14m | 134.97m | 140.73m | 135.21m | 132.1m | 132.1m |
| OCF | Operating Cash Flow |
|
$-7.72M | $-13.00M | $7.08M | $-0.15M | $-35.37M | $-40.15M | $-45.39M | $-34.30M | $-64.28M | $-49.34M | $-47.52M | $-37.08M | $-50.38M | $134.05M | $-49.50M | $-85.42M | $55.45M | $299.44M | $240.11M | $0.00M | $0.00M |
| FCF | Free Cash Flow |
|
$-7.95M | $-13.35M | $6.72M | $-2.52M | $-36.53M | $-41.61M | $-46.04M | $-35.18M | $-65.74M | $-51.64M | $-48.89M | $-39.44M | $-53.52M | $132.70M | $-54.16M | $-89.46M | $52.95M | $297.98M | $235.30M | $302.00M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.22 | $-0.27 | $0.11 | $-0.03 | $-0.46 | $-0.48 | $-0.49 | $-0.34 | $-0.59 | $-0.46 | $-0.40 | $-0.31 | $-0.42 | $0.97 | $-0.38 | $-0.62 | $0.39 | $2.12 | $1.72 | $0.00 | $0.00 |